SCHEMBL736822

SCHEMBL736822

CC(C)(N)C(=O)N[C@H](Cc1csc2ccccc12)C(=O)N[C@H](Cc1csc2ccccc12)NS(C)(=O)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.50
GHSR Q92847 2/20 0.50
CTSL P07711 1/20 0.48
CTSS P25774 1/20 0.48
CTSK P43235 1/20 0.48
MMP2 P08253 2/20 0.44
MMP9 P14780 2/20 0.44
MMP8 P22894 2/20 0.44
TACR1 P25103 1/20 0.41
F10 P00742 2/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
KLKB1 P03952 3/20 0.38
KLK1 P06870 2/20 0.38
MMP1 P03956 1/20 0.38
MMP3 P08254 1/20 0.38
MMP14 P50281 1/20 0.38
MMP25 Q9NPA2 1/20 0.38
OPRD1 P41143 2/20 0.35
OPRK1 P41145 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL737102 0.94 GHSR (0.45) OPRM1GHSRCTSLCTSSCTSK
SCHEMBL736855 0.94 GHSR (0.45) OPRM1GHSRCTSLCTSSCTSK
SCHEMBL737524 0.91 GHSR (0.65) OPRM1GHSRCTSLCTSSCTSK
SCHEMBL738184 0.91 GHSR (0.65) OPRM1GHSRCTSLCTSSCTSK
SCHEMBL736937 0.90 GHSR (0.42) OPRM1GHSRCTSLCTSSCTSK
SCHEMBL737199 0.90 CTSS (0.42) OPRM1GHSRCTSLCTSSCTSK
SCHEMBL737818 0.87 GHSR (0.52) OPRM1GHSRCTSLCTSSCTSK
SCHEMBL737099 0.85 GHSR (0.68) OPRM1GHSRCTSLCTSSCTSK
SCHEMBL760986 0.83 MMP2 (0.60) OPRM1GHSRCTSLCTSSCTSK
SCHEMBL737510 0.82 CTSL (0.42) OPRM1GHSRCTSLCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138218-B2 Growth hormone secretagogues IPSEN PHARMA S.A.S. (FR) 2012-03-20 US disclosed
US-20090131478-A1 Growth Hormone Secretagogues IPSEN PHARMA S.A.S. (FR) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131478-A1 Growth Hormone Secretagogues GHSR, GHRHR, GHITM OPRM1 3398/4885GHSR 1/4885CTSL 590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.